Trial intelligence / Profile preview

Tetraspan vs HES 130/0.4 in Elective Surgery

NCT01301469Phase 3Completed

Sponsor
B. Braun
Start
Feb 2011
Primary completion
Jul 2011
Modality
Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
Countries
1
01

Overview

A Phase 3 trial of hetastarch in hypovolemia, sponsored by B. Braun. Started Feb 2011; status: completed.

02

Drugs

hetastarch
03

Conditions

hypovolemia

Beyond the preview

Go deeper on NCT01301469.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01301469.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call